User Evaluation of BGM JS200B
Not Applicable
Completed
- Conditions
- Diabetes
- Registration Number
- NCT06037538
- Lead Sponsor
- Institut fur Diabetes Karlsburg GmbH
- Brief Summary
Performance Evaluation by the User of the Blood Glucose Monitoring System JS200B in accordance with DIN EN ISO 15197:2015
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Analysis of system accuracy based on DIN EN ISO 15197 Day 1 Assessment of the analytical measurement performance of the blood glucose monitor
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie JS200B's glucose detection accuracy according to ISO 15197:2015 standards?
How does JS200B's user performance compare to traditional fingerstick methods in type 1/2 diabetes management?
What biomarkers correlate with JS200B's reliability in NCT06037538's hypoglycemic patient population?
What adverse events are associated with JS200B use and how do they compare to other continuous glucose monitoring systems?
How does TysonBio's JS200B integrate with existing diabetes therapies like insulin or GLP-1 agonists for improved outcomes?
Trial Locations
- Locations (1)
Institut für Diabetes Karlsburg GmbH
🇩🇪Karlsburg, Mecklenburg Vorpommern, Germany
Institut für Diabetes Karlsburg GmbH🇩🇪Karlsburg, Mecklenburg Vorpommern, Germany